Nektar Therapeutics (NKTR) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

NKTR is expected to report earnings to fall 26.00% to -18 cents per share on November 06

Nektar Therapeutics NKTR Stock Earnings Reports

Q3'24

Est.

$-0.19

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.04

Q4'23

Missed

by $0.02

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -25 cents, missing the estimate of -18 cents. With 966.20K shares outstanding, the current market capitalization sits at 215.37M.

View a ticker or compare two or three

Compare

NKTR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For NKTR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

455 Mission Bay Boulevard South

Phone

+1 415 482-5300

Employees

137

Web

https://www.nektar.com